The name is absent



35

Table 2.3: Marginal posterior cell probabilities (central 95% credible intervals) of
toxicity. The table only reports grades up to
к — 3. The marginal probabilities for
grade G4 abnormal vision are 0 (with 95% C.I. (0,0.002)) under placebo, and 0.001
(with 95% C.I., (0,0.002)) under isotretinoin.

Toxic effect  No Tox            Gl                G2                G3

Placebo

Abn. vision  0.974 (0.962, 0.985)  0.02 (0.011, 0.033)   0.002 (0.001, 0.005)  0.003 (0.001, 0.006)

Arthralgia  0.937 (0.918, 0.954)  0.042 (0.029, 0.057)  0.019 (0.013, 0.026)  0.002 (0.001, 0.005)

Cheilitis  0.808 (0.774, 0.84)   0.172 (0.145, 0.201)  0.02 (0.012, 0.03)     0 (0, 0)

Conjunctivitis  0.896 (0.872, 0.918)  0.077 (0.063, 0.093)  0.025 (0.015, 0.036)  0.001 (0, 0.002)

Fatigue  0.967 (0.952, 0.978)  0.024 (0.015, 0.035)  0.009 (0.005, 0.015)  0.001 (0, 0.001)

Headache  0.962 (0.945, 0.976)  0.029 (0.017, 0.044)  0.008 (0.004, 0.013)  0.001 (0, 0.003)

H.-triglyceride  0.971 (0.955, 0.983)  0.028 (0.017, 0.042)  0.001 (0, 0.003)      0 (0, 0)

Isotretinoin

Abn. vision  0.972 (0.958, 0.983)  0.023 (0.013, 0.035)  0.002 (0, 0.004)      0.003 (0.001, 0.006)

Arthralgia  0.922 (0.9, 0.941)    0.054 (0.039, 0.073)  0.021 (0.014, 0.028)  0.003 (0.002, 0.006)

Cheilitis 0.398 (0.355,0.443) 0.403 (0.365,0.439) 0.177 (0.153,0.203) 0.022 (0.015,0.031)

Conjunctivitis  0.777 (0.739, 0.814)  0.163 (0.133, 0.196)  0.052 (0.04, 0.066)   0.007 (0.004, 0.011)

Fatigue  0.959 (0.943, 0.973)  0.029 (0.019, 0.042 )  0.011 (0.006, 0.017)  0.001 (0, 0.002)

Headache  0.968 (0.953, 0.98)   0.024 (0.015, 0.036)  0.007 (0.004, 0.012)  0.001 (0, 0.002)

H.-triglyceride  0.851 (0.82, 0.879)   0.086 (0.064, 0.11)   0.056 (0.038, 0.075)  0.007 (0.002, 0.013)



More intriguing information

1. Ability grouping in the secondary school: attitudes of teachers of practically based subjects
2. The name is absent
3. Social Irresponsibility in Management
4. Poverty transition through targeted programme: the case of Bangladesh Poultry Model
5. THE MEXICAN HOG INDUSTRY: MOVING BEYOND 2003
6. The Prohibition of the Proposed Springer-ProSiebenSat.1-Merger: How much Economics in German Merger Control?
7. The Role of Trait Emotional Intelligence (El) in the Workplace.
8. A Rare Presentation of Crohn's Disease
9. The name is absent
10. The Value of Cultural Heritage Sites in Armenia: Evidence From a Travel Cost Method Study